Recompensation of decompensated cirrhosis in a spectrum of metabolic-dysfunction-related steatotic liver disease, with PEth-corroborated alcohol abstinence and modification of cardiometabolic risk factors
{{output}}
Background aims: Recompensation of decompensated metabolic-dysfunction-associated steatotic liver disease (MASLD) and Metabolic Dysfunction-Associated Steatotic Liver Disease with Alcohol Consumption (MetALD) cirrhosis remains un... ...
